SubbaRao V Tulimilli

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Coronavirus Disease

Anti Inflammatory

Angiotensin Converting Enzyme

Top Venues

Pathogens (Basel, Switzerland)

Diseases (Basel, Switzerland)

BioMed research international

Journal of materials chemistry. B

This page only lists publications with an associated author ORCID identifier.

Publications

Prashanth Chikkahonnaiah, Siva Dallavalasa, SubbaRao V Tulimilli, Muskan Dubey, Shashidhar H Byrappa, Raghavendra G Amachawadi, SubbaRao V Madhunapantula, Ravindra P Veeranna
SARS-CoV-2 Infection Positively Correlates with Hyperglycemia and Inflammatory Markers in COVID-19 Patients: A Clinical Research Study. Diseases (Basel, Switzerland) 12 (7) (2024)
Prashanth Chikkahonnaiah, Siva Dallavalasa, SubbaRao V Tulimilli, Muskan Dubey, Shashidhar H Byrappa, Raghavendra G Amachawadi, SubbaRao V Madhunapantula, Ravindra P Veeranna
SARS-CoV-2 Infection Positively Correlates with Hyperglycemia and Inflammatory Markers in COVID-19 Patients: A Clinical Research Study. Diseases (Basel, Switzerland) 12 (7) (2024)
Prashanth Chikkahonnaiah, Siva Dallavalasa, SubbaRao V Tulimilli, Muskan Dubey, Shashidhar H Byrappa, Raghavendra G Amachawadi, SubbaRao V Madhunapantula, Ravindra P Veeranna
SARS-CoV-2 Infection Positively Correlates with Hyperglycemia and Inflammatory Markers in COVID-19 Patients: A Clinical Research Study. Diseases (Basel, Switzerland) 12 (7) (2024)
Siva Dallavalasa, SubbaRao V Tulimilli, Janhavi Prakash, Ramya Ramachandra, SubbaRao V Madhunapantula, Ravindra P Veeranna
COVID-19: Diabetes Perspective-Pathophysiology and Management. Pathogens (Basel, Switzerland) 12 (2) (2023)
Siva Dallavalasa, SubbaRao V Tulimilli, Janhavi Prakash, Ramya Ramachandra, SubbaRao V Madhunapantula, Ravindra P Veeranna
COVID-19: Diabetes Perspective-Pathophysiology and Management. Pathogens (Basel, Switzerland) 12 (2) (2023)
Siva Dallavalasa, SubbaRao V Tulimilli, Janhavi Prakash, Ramya Ramachandra, SubbaRao V Madhunapantula, Ravindra P Veeranna
COVID-19: Diabetes Perspective-Pathophysiology and Management. Pathogens (Basel, Switzerland) 12 (2) (2023)
Siva Dallavalasa, SubbaRao V Tulimilli, Janhavi Prakash, Ramya Ramachandra, SubbaRao V Madhunapantula, Ravindra P Veeranna
COVID-19: Diabetes Perspective-Pathophysiology and Management. Pathogens (Basel, Switzerland) 12 (2) (2023)
Sharon George, Asha Srinivasan, SubbaRao V Tulimilli, SubbaRao V Madhunapantula, Shajesh Palantavida
Folate targeting self-limiting hyperthermic nanoparticles for controlled photothermal therapy. Journal of materials chemistry. B (2023)
Narasimha M Beeraka, SubbaRao V Tulimilli, Medha Karnik, Surya P Sadhu, Rajeswara Rao Pragada, Gjumrakch Aliev, SubbaRao V Madhunapantula
The Current Status and Challenges in the Development of Vaccines and Drugs against Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2). BioMed research international 2021 (2021)